🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 128-week open-label study to assess the long-term safety and tole...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-30
Trial ID
NCT04084314
Treatments Being Tested
Migraine, a complex and multifaceted disorder, remains only partially under...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06692088
Considering the compelling amount of studies focused on patients in the act...
Status
Recruiting
Location
Federico II University of Naples
Start Date
2022-01-27
Trial ID
NCT05293366
Treatments Being Tested
Osteoporotic fracture is a common public-health problem in the whole world....
Status
Completed
Location
Department of Family Medicine, National Cheng Kung Univ Hosp
Start Date
2020-11-01
Trial ID
NCT05366621
Treatments Being Tested
A randomized, double-blind, placebo-controlled, parallel study to investiga...
Status
Unknown
Location
Danish Headache Center
Start Date
2020-07-22
Trial ID
NCT04452929
Treatments Being Tested
The goal of this observational study is to evaluate clinical differences in...
Status
Recruiting
Location
University of Miami, Miller School of Medicine
Start Date
2024-01-02
Trial ID
NCT07159750
Treatments Being Tested
The investigators aim to investigate the incidence of migraine attacks afte...
Status
Unknown
Location
Danish Headache Center, Rigshospitalet Glostrup
Start Date
2016-07
Trial ID
NCT03481400
Treatments Being Tested
The term "refractory" migraine describes a particularly aggressive form of ...
Status
Unknown
Location
Headache Science Center
Start Date
2021-09-15
Trial ID
NCT05046119
Vestibular migraine is a phenotype of migraine, characterized by more promi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12
Trial ID
NCT07203248
Treatments Being Tested
Erenumab, a monoclonal antibody acting on the calcitonin gene-related pepti...
Status
Completed
Location
University of L'Aquila
Start Date
2021-07-01
Trial ID
NCT04659226
Treatments Being Tested